目的報告1例分期肝腎聯合移植,并探討分期肝腎聯合移植治療技術及其效果。方法對1例晚期乙型肝炎肝硬變伴腎功能衰竭患者實施原位肝移植術,所用免疫抑制方案為環孢霉素A與甲基強的松龍聯合用藥,于肝移植術后3個月行腎移植術。結果肝移植術后肝功能恢復良好,但腎功能持續惡化,經血液透析治療無效而行腎移植術。患者肝腎聯合移植術后9個月,一般情況良好,移植肝和移植腎功能均正常。結論對肝移植后各種原因導致的腎功能衰竭,當血液透析治療無效時可再行腎移植術。同時,免疫抑制劑用量并未增加。
引用本文:
王學浩,吳宏飛,張峰,錢建民,錢立新,李相成,劉軍,李國強,成峰. 分期肝腎聯合移植1例報告△. 中國普外基礎與臨床雜志, 2003, 10(1): 49-50. doi:
復制
1. |
Jeyarajah DR, Gonwa TA, McBride M, et al. Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant [J]. Transplantation, 1997; 64(12)∶ 1760.
|
2. |
PerezCerda F, Moreno Gonzalez E, de Bobadilla AS, et al. Anesthetic support in synchronous liver and kidney transplantation [J]. Hepatogastroenterology, 1998; 45(23)∶1821.
|
- 1. Jeyarajah DR, Gonwa TA, McBride M, et al. Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant [J]. Transplantation, 1997; 64(12)∶ 1760.
- 2. PerezCerda F, Moreno Gonzalez E, de Bobadilla AS, et al. Anesthetic support in synchronous liver and kidney transplantation [J]. Hepatogastroenterology, 1998; 45(23)∶1821.